Posted on behalf of Dr. Xinlai Cheng

 

In the Department of Biochemistry, Chemistry and Pharmacy - Institute of
Pharmaceutical Chemistry in the field of Medicinal Chemistry -  Dr. Xinlai
Cheng offers a position starting instantly of a PhD-Student/ Research
Associate (E13 TV-G-U, 50 % part-time).

 

limited up to 31.12.2022 (possible expansion to 31.12.2025). The salary
grade is based on the job characteristics of the collective agreement
applicable to Goethe University (TV-G-U).

 

Link to job webpage –
https://www.uni-frankfurt.de/48794939/FB14___Biochemie__Chemie_und_Pharmazie

 

 

Area of responsibility

 

The work will be done in a multi-disciplinary research environment
encompassing medicinal chemistry, stem cell and chemotherapy. The candidate
will work at the Buchmann Institute for Molecular Life
Sciences/Pharmaceutical Chemistry (Frankfurt am Main). The work will be
performed in close collaboration with other research groups in Frankfurt,
Heidelberg and Jena.

 

We are looking for a PhD-student (graduate student) who is interested to
work on a challenging project at the interface of chemistry, biochemistry
and (stem) cell biology. The aim of our project is to identify new bioactive
compounds and study the mechanism of action for regenerative medicine and
cancer therapy.

 

The candidate will be offered the opportunity to do self-directed research
and develop further scientific qualification.

 

Employment requirements

 

Applicants should have a master degree (or equal) in organic chemistry and
medicinal chemistry. The candidate should have experience in organic
synthesis, and in particular heterocyclic compounds synthesis. Knowledge on
the application of novel synthetic methodologies and PROTAC will be
advantageous. High level knowledge and good communication skills in English
and German are expected.

 

In order to increase the proportion of women in research, we particularly
encourage women to apply for this position. Disabled people will be
considered preferentially in the case of equal aptitude.

 

The planned research will be carried out in an international research
environment at the Life Science Campus Riedberg. Interested candidates are
encouraged to send applications until July, 22th 2020 to the following
e-mail address: Dr. rer.nat.habil.  Xinlai Cheng,
ch...@pharmchem.uni-frankfurt,de <mailto:ch...@pharmchem.uni-frankfurt,de> ,
Goethe-Universität, Buchmann Institute for Molecular Life Sciences;
Pharmaceutical Chemistry; Max-von-Laue-Strasse 15. R. 3.652 ; 60438
Frankfurt am Main.

 

Best,

Dr. Xinlai Cheng


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to